BioSpace News Archive

Bio NC

G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey, G1’s Chief Executive Officer, and other members of the executive team will participate virtually in the H.C. Wainwright 24th Annual Global Investment Conference.

September 7, 2022
·
1 min read
Biotech Bay

Tempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Tempest Therapeutics, Inc. announced that Stephen R. Brady, chief executive officer of Tempest, will present at the H.C. Wainwright 24th Annual Global Investment Conference.

September 7, 2022
·
1 min read
Pharm Country

Outlook Therapeutics® to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Outlook Therapeutics, Inc. announced that Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY and virtually on September 12-14, 2022.

September 7, 2022
·
1 min read
Medical and Biological Sensors Market Size up to 2030 – Quantitative Research by QYResearch Medical

A biological or medical sensor or biosensor is a medical device formed by incorporation of an electrical transducer with a biological element such as enzyme, mineral, nucleic acid, protein, or antibodies.

September 7, 2022
·
4 min read
North America Laboratory Informatics Market 2022 Industry Growth, Top Key Players, Segmentation and Forecast till 2030

According to Nova one advisor, the North America Laboratory Informatics market gathered revenue around USD 6.9 billion by the end of 2030 and is estimated to expand at a modest CAGR of 8.8%during the prediction period 2022 to 2030.

September 7, 2022
·
8 min read
North America Life Science Tools Market Size to Surpass USD 83.9 Bn by 2030

The North America Life Science Tools market size was estimated at USD 34.8 billion in 2021 and is expected to surpass around USD 83.9 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 13.6% during the forecast period 2022 to 2030.

September 7, 2022
·
12 min read
Pharm Country

FDA Accepts Integral Molecular’s Letter of Intent (LOI) on Membrane Proteome Array Antibody Specificity Test Into ISTAND Drug Development Tools Pilot Program

Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & Drug Administration (FDA)'s ISTAND pilot program.

September 7, 2022
·
2 min read
Policy

Veru Announces Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Veru Inc. announced that the U.S. Food and Drug Administration has informed the Company that FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet to discuss the Company’s request for Emergency Use Authorization of sabizabulin for hospitalized COVID-19 patients at high risk for ARDS.

September 7, 2022
·
10 min read
BioCapital

Indivior To Participate in Upcoming Investor Healthcare Events in September 2022

Indivior PLC announced that it will participate in the following investor healthcare events.

September 7, 2022
·
2 min read
Biotech Beach

NKGen Biotech to Present at the Baird 2022 Global Healthcare Conference

NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today announced that its senior management will present at the Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022, in New York City.

September 7, 2022
·
1 min read